Ultimovacs
A pharmaceutical company developing novel immunotherapies against cancer. Learn more
Launch date
Employees
Market cap
€7.1m
Enterprise valuation
(€11m) (Public information from Sep 2024)
Share price
NOK1.77 ULTI.OL
Company register number 996713008
Oslo Norway (HQ)
Authorizing premium user...